Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - IMMUCELL CORP /DE/ | exh99_1.htm |
| EX-99.2 - EXHIBIT 99.2 - IMMUCELL CORP /DE/ | exh99_2.htm |
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
|
|
Date of Report: December 08, 2011
(Date of earliest event reported)
|
||
|
ImmuCell Corporation
(Exact name of registrant as specified in its charter)
|
||
|
DE
(State or other jurisdiction
of incorporation)
|
001-12934
(Commission File Number)
|
01-0382980
(IRS Employer
Identification Number)
|
|
56 Evergreen Drive
Portland, Maine
(Address of principal executive offices)
|
04103
(Zip Code)
|
|
|
207-878-2770
(Registrant's telephone number, including area code)
|
||
|
Not Applicable
(Former Name or Former Address, if changed since last report)
|
||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events
ImmuCell Corporation (the “Company”) issued a press release regarding its Mast Out® product offering as presented at the World Animal Health Congress in Kansas City, MO. on December 8, 2011.
Item 9.01. Financial Statements and Exhibits
(c) Exhibits
99.1 Press Release of ImmuCell Corporation, dated December 8, 2011
99.2 White Paper: Treating Mastitis Without a Loss of Milk Revenue
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Dated: December 8, 2011
|
IMMUCELL CORPORATION |
|
|
|
| By: /s/ Michael F. Brigham | |
| Michael F. Brigham | |
| President and CEO |
| Exhibit Index | |||
| Exhibit No. | Description | ||
| 99.1 | Press Release of ImmuCell Corporation dated | ||
| December 08, 2011 | |||
| 99.2 | White Paper: Treating Mastitis Without a Loss of | ||
| Milk Revenue | |||